Application 210915

Type
ANDA
Sponsor
TEVA PHARMS USA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TOBRAMYCINTOBRAMYCINSOLUTION;INHALATION300MG/4MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0093-3750TobramycinTobramycinTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-3750TobramycinTobramycinTeva Pharmaceuticals USA, Inc.ANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
59242ORIG2019-07-05